Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

NCT04365374 · tracked via the Priya Life Science USA tracker

Sponsor

GT Medical Technologies, Inc.

Phase

Phase 3

Started

2021-04-06

Last updated

—

Condition(s) studied

Brain Metastases

More GT Medical Technologies, Inc. trials in the USA

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) Recruiting

GammaTile and Stupp in Newly Diagnosed GBM Active, not recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care Recruiting

Other trials for the same condition

REMASTer: REcurrent Brain Metastases After SRS Trial Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04365374 on ClinicalTrials.gov ↗ ← All trials in the USA